ICI176,334-1

DRUG4 trials

Sponsors

AstraZeneca

Conditions

Healthy

Phase 1

Oral Mucosal Absorption of ICI176,334-1

CompletedNCT01415791

AstraZenecaHealthy

Start: 2011-08-31End: 2011-09-30Updated: 2012-05-30

Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

CompletedNCT01415778

AstraZenecaHealthy

Start: 2011-08-31End: 2011-12-31Updated: 2012-05-30

Oral Mucosal Absorption Study of Bicalutamide New Formulation

TerminatedNCT01416883

AstraZenecaHealthy

Start: 2010-07-31End: 2010-08-31Updated: 2011-08-15

Bioequivalence of Bicalutamide New Formulation in Japan

TerminatedNCT01416870

AstraZenecaHealthy

Start: 2010-07-31End: 2010-11-30Updated: 2012-01-11